Figure 1.
miR-181 expression in patients with cisplatin-induced NSCLC. Control, paracarcinoma tissue group; cisplatin-NSCLC, cisplatin-resistant NSCLC. ##p<0.01 vs. paracarcinoma tissue group. NSCLC, non-small-cell lung cancer.
miR-181 expression in patients with cisplatin-induced NSCLC. Control, paracarcinoma tissue group; cisplatin-NSCLC, cisplatin-resistant NSCLC. ##p<0.01 vs. paracarcinoma tissue group. NSCLC, non-small-cell lung cancer.